References
Muller U, Jongeneel CV, Nedopasov SA, Lindahl KF, Steinmetz M: Tumor necrosis factor and lymphotoxin genes map close to H-2D in mouse major histocompatibility complex. Nature 1987;325:265–267.
Nedwin GE, Naylor SL, Sakaguchi AY, Smith D, Jarrett-Nedwin J, Pennica D, Goeddel DV, Gray PW: Human lymphotoxin and tumor necrosis factor genes: Structure, homology, and chromosomal localization. Nucleic Acids Res 1985;13:6361.
Ragoussis J, Bloemer K, Weiss EH, Ziegler A: Localization of the genes for tumor necrosis factor and lymphotoxin between the HLA class I and III regions by field inversion gel electrophoresis. Immunogenetics 1988;27:66.
Spies T, Morton CC, Nedospasov SA, Fiers W, Pious D, Strominger JL: Genes for the tumor necrosis factors α and β are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA 1986;83:8699–8702.
Carroll MC, Katzman P, Alicot EM, Koller BH, Geraghty DE, Orr HT, Strominger JL, Spies T: Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci USA 1987;84:8535–8539.
Dunham I, Sargent CA, Trowsdale J, Campbell RD: Molecular mapping of the human major histocompatibility complex by pulse field gel electrophoresis. Proc Natl Acad Sci USA 1987;84:7237–7241.
Svejgaard A, Platz P, Ryder LP: HLA and Disease: A survey. Immunol Rev 1983;70:193–218.
Tiwari JL, Terasaki PI: HLA and Disease Associations. Berlin, Springer, 1985.
Jacob CO, McDevitt HO: Tumor necrosis factor-α in murine autoimmune ‘lupus’ nephritis. Nature 1988;331:356–358.
Bottazzo GF, Pujol-Borrell R, Hanafusa T: Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983;ii:1115–1119.
Theofilopoulos AN, Dixon FJ: Etiopathogenesis of murine SLE. Immunol Rev 1981;55:179–216.
Reinertsen JL, Klippel JH, Johnson AH, Steinberg AD, Decker JL, Mann DL: B-lymphocyte alloantigens associated with systemic lupus erythematosus. N Engl J Med 1978;299:515.
Howie JB, Helyer FJ: The immunology and pathology in NZB mice. Adv Immunol 1968;9:215–266.
Kotzin BL, Palmer ED: The contribution of NZW genes to lupus-like disease in (NZB×NZW)F1 mice. J Exp Med 1987;165:1237.
Jacob CO, Fronek Z, McDevitt HO: Immunogenetics of systemic lupus erythematosus; in Immunogenetics of Autoimmune Diseases. Boca Raton, CRC Press, in press.
Jacob CO, Van der Meide PH, McDevitt HO: In vivo treatment of (NZB×NZW)F1 lupus-like nephritis with monoclonal antibody to γ interferon. J Exp Med 1987;166:798–803.
Wong GHW, Goeddel DV: Tumor necrosis factor a and β inhibit virus replication and synergize with interferons. Nature 1986;323:819–822.
Patton JS, Shepard MH, Wilking H, Lewis GD, et al: Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. Proc Natl Acad Sci USA 1986;83:8313–8317.
Pujol-Borrell R, Todd I, Doshi M, Bottazzo GF, Sutton R, Gray D, Adolf GR, Feldman M: HLA class II induction in human islet cells by interferon-γ plus tumor necrosis factor or lymphotoxin. Nature 1987;326:304–306.
Mukavitz-Kramer S, Carver ME: Serum-free in vitro bioassay for the detection of tumor necrosis factor. J Immunol Methods 1986;93:201–206.
Gordon C, Ranges GE, Greenspan JS, Wofsy D: Chronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/NZW F1 mice. J Immunol Immunopathol 1989;52:421–434.
Boswell JM, Yui MA, Burt DW, Kelley VE: Increased tumor necrosis factor and IL-1β gene expression in the kidneys of mice with lupus nephritis. J Immunol 1988;141:3050.
Brennan DC, Yui MA, Wuthrich RP, Kelley VE: Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury. J Immunol 1989;143:3470–3475.
Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinareilo CA, Svensen M: Cytotoxicity of human p17 interleukin-1 for pancreatic islets of Langerhans. Science 1986;232:1545–1547.
Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH: Affinity-purified human IL-1 is cytotoxic to isolated islets of Langerhans. Diabetologia 1986;29:63.
Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J: Human TNF potentiates human IL-1 mediated pancreatic β-cell cytotoxicity. J Immunol 1987;139:4077–4082.
Bendtzen K: Immune hormones (cytokines): Pathogenic role in autoimmune rheumatic and endocrine diseases. Autoimmunity 1989;2:177–189.
Held W, MacDonald HR, Weissman IL, Hess MW, Mueller C: Gene encoding tumor necrosis factor α and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci USA 1990;87:in press.
Campbell IL, Cutri A, Wilkinson D, Boyd AW, Harrison LC: Intercellular adhesion molecule 1 is induced on isolated endocrine islet cells by cytokines but not by reovirus infection. Proc Natl Acad Sci USA 1989;86:4282–4286.
Jacob CO, Also S, Michie SA, McDevitt HO, Acha-Orbea H: Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor: Similarities between TNF-α and IL-1. Proc Natl Acad Sci USA 1990;87:968–972.
Satoh J, Seino H, Abo T, Tanaka S, Shintani S, Ohta S, Tamura K, Sawai T, Nobunaga T, Otchi T, Kumagai K, Toyota T: Recombinant human TNF-α suppresses autoimmune diabetes in NOD mice. J Clin Invest 1989;84:1345–1348.
Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor-α: Relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990;87:1233–1237.
Bendtzen K, Morling N, Fomsgaard A, Svenson M, Jakobsen BK, Odum N, Svejgaard A: Association between HLA-DR2 and production of tumor necrosis factor alfa and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol 1988;28:599–606.
Molvig J, Back L, Manogue KR, Christensen P, Nielsen LS, Vlassara H, Platz P, Neriys J: Are stable interindividual differences in IL-1, TNF, and PGE2 secretion from low dose LPS stimulated human monocytes associates with HLA-D region genes? Scand J Immunol 1988;27:705–716.
Santamaria P, Gehrz RC, Bryan MK, Barbosa JJ: Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretion by human monocytes. J Immunol 1989;143:919–922.
Choo SY, Spies T, Strominger JL, Hansen J: Polymorphism in the tumor necrosis factor gene: Association with HLA-B and DR haploytypes. Hum Immunol 1988;23:86.
Fugger L, Morling N, Ryder LP, Georgesen J, Jakobsen BK, Svejgaard A, Andersen V, Oxholm P, Karup Pedersen F, Friis J, Halberg P: NcoI restriction fragment length polymorphism of the TNF-α region in four autoimmune diseases. Tissue Antigens 1989;34:17–22.
Fugger L, Morling N, Ryder LP, Platz P, Georgsen J, Jakobsen BK, Svejgaard A, Dalhoff K, Ranek L: NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNFα) region in primary biliary cirrhosis and in healthy Danes. Scand J Immunol 1989;30:185–189.
Fugger L, Bendtzen K, Morling N, Ryder L, Svejgaard A: Possible corrleation of TNF-α-production with-RFLP in man. Eur J Haematol 1989;43:255–256.
Dawkins RL, Leaver A, Cameron PV, Martin E, Kay PH, Christiansen FT: Some disease-associated ancestral haplotypes carry a polymorphism of TNF. Hum Immunol 1989;26:91–97.
Chang RJ, Lee SH: Effect of interferon-γ and TNF-α on the expression of an Ia antigen on a murine macrophage cell line. J Immunol 1986; 137:2853–2856.
Pfizenmaler K, Scheurich P, Schluter C, Kronke M: Tumor necrosis factor enhances HLA-A, B, C, and HLA-DR gene expression in human tumor cells. J Immunol 1987;138:975–980.
Arenzana-Seidedos F, Mogensen SC, Vuillier F, Fiers W, Virelizier JL: Autocrine secretion of tumor necrosis factor under the influence of interferon-γ amplifies HLA-DR gene induction in human monocytes. Proc Natl Acad Sci USA 1988; 85:6087–6091.
Hoffman M, Weinberg JB: Tumor necrosis factor-a induces increased hydrogen peroxide production and Fc receptor expression, but not increased Ia antigen expression by peritoneal macrophages. J Leukocyte Biol 1987;42:704–707.
Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666–3670.
Signore A, Cook A, Pozilli P, et al: Class II and IL-2 receptor-positive cells in the pancreas of NOD mice. Diabetologia 1987;30:902–905.
Fronek Z, Timmerman LA, Alper CA, Hahn BH, Kalunian K, Peterlin BM, McDevitt HO: Major histocompatibility complex association with systemic lupus erythematosus. Am J Med 1988;85:42–44.
Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A: Control of cachectin (tumor necrosis factor) systhesis: Mechanisms of endotoxin resistance. Science 1986;232:977–979.
Waage A, Bakke O: Glucocorticoids suppress the production of tumor necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology 1988;63:299.
Zimmer T, Jones PP: Combined effects of tumor necrosis factor-α, prostaglandin E2, and corticosterone on induced Ia expression on murine macrophages. J Immunol 1990;145:1167–1175.
Fronek Z, Timmerman LA, Alper CA, Hahn BH, Kalunian K, Peterlin BM, McDevitt HO: Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. Arthritis Rheum 1990;33:1542–1553.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jacob, C.O., Lewis, G.D. & McDevitt, H.O. MHC class II-associated variation in the production of tumor necrosis factor in mice and humans: Relevance to the pathogenesis of autoimmune diseases. Immunol Res 10, 156–168 (1991). https://doi.org/10.1007/BF02918162
Issue Date:
DOI: https://doi.org/10.1007/BF02918162